News

The disease is now widespread among rodents in New Orleans, posing an increased public health risk of rat lungworm disease to people in the area.

Health officials are investigating an outbreak of Listeria monocytogenes in 4 states with a suspected link to ready-to-eat pork products.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.

The new response program will focus on scaling up prevention and treatment efforts for malaria and increasing financial investments to better protect vulnerable populations.

Sixteen WHO health workers have been evacuated from the epicenter of the outbreak following an attack on their residence.

As resistance, and incidence, are both on the rise, new options may come not a moment too soon.

Additionally, its use is associated with colonization of the gastrointestinal tract by lower relative quantities of some potentially protective bacterial organisms.

The CDC is advising all Americans to avoid romaine lettuce products until a source can be identified in an outbreak of Shiga toxin producing-E coli O157:H7 affecting 11 states and Canada.

New research finds it is safe to use gentamicin to treat bacteremia, provided it is used for a short term and only given once per day.

The FDA has accepted a supplemental NDA that seeks to expand the label of ceftazidime and avibactam to include the treatment of cUTI and cIAI in children older than 3 months.

Sahil Khanna, MBBS, MS, discusses the efficacy of fecal transplants and new investigational candidates that are being evaluated in clinical trials.

A new survey has found that 34% of US parents are not planning to have their child vaccinated against influenza.

A new study found that poor sleep quality, poor sleep duration, problems falling asleep, and problems staying awake during wake-time activities were associated with risky sexual behavior.

The latest report from WHO highlights trends in antimicrobial consumption and use across the world, underscoring the need for international antimicrobial stewardship programs.

In 2015, 60% of foodborne illness outbreaks were associated with restaurants.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

The FDA has approved the antibiotic for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of E coli not complicated by fever or blood in the stool.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

As antimicrobial therapies become less effective, more people are at risk for infections that can progress to sepsis.

A study found that while MSM who have used stimulant or non-stimulant substances had increased rates of STIs, PrEP adherence was not decreased by substance use.

Two new studies highlight how antibodies from prior infection with Zika or Dengue may increase the severity of illness in the other, impacting the infants of pregnant women who are infected.

A new study reveals that the type of surgery performed to treat these infections plays a more significant role in outcomes than other factors.

Saskia Popescu, MPH, MA, CIC, reports from the 5th Ministerial Meeting of the Global Health Security Agenda.

The follicular phase of the menstrual cycle may be the most vulnerable time for HIV-1 acquisition in women—not the luteal phase, as previously thought.

Glenn Tillotson, PhD discusses the development of new antibiotics and therapies for C diff during an era when antibiotic resistance is a serious global health threat.

A new study suggests in people living with HIV, metabolic risk factors including low HDL, hypertriglyceridemia and BMI were associated with nonalcoholic fatty liver disease.

New report highlights risks and costs associated with these infections equal to roughly 1 million deaths and $65 billion in the United States.

A new approach to hepatitis C virus infection treatment could shave time and costs off the current standard regimen.